Drugs / Human Umbilical Cord Blood Plasma
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03229785 | Apr 2018 → Jan 2019 | — | Hexagon Therapies, LLC | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Human Umbilical Cord Blood Plasma | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03229785 ↗ |
| Route | Intravenous | “Six intravenous infusions of human umbilical cord blood plasma (HUCBP) during a twelve month study period.” NCT03229785 ↗ |